Market Place
Sourcing Support
Capricor Therapeutics Reports Q4 & FY 2025 Results
12 Mar 2026 //
GLOBENEWSWIRE
Capricor Therapeutics to Present Q4 and Financial Results 2025
09 Mar 2026 //
GLOBENEWSWIRE
Capricor Updates on Deramiocel BLA Post FDA Review OF Data
21 Jan 2026 //
GLOBENEWSWIRE
Capricor Pharma Prices $150M Public Stock Offering
05 Dec 2025 //
GLOBENEWSWIRE
Capricor Therapeutics Plans Public Stock Offering
04 Dec 2025 //
GLOBENEWSWIRE
FDA Reversals Plunge Uniqure, Biohaven, Capricor Into Tailspin
24 Nov 2025 //
BIOSPACE
Capricor Therapeutics Unveils Scalable Exosome Data at AAEV 2025
24 Nov 2025 //
GLOBENEWSWIRE
Capricor Therapeutics Unveils Q3 Financials & Corporate Updates
10 Nov 2025 //
GLOBENEWSWIRE
Capricor Therapeutics To Unveil Q3 2025 Financials & Corporate
31 Oct 2025 //
GLOBENEWSWIRE
Capricor Doses First Subjects in Phase 1 Trial of Exosome Vaccine
18 Aug 2025 //
GLOBENEWSWIRE
Capricor Therapeutics Q2 2025 Financial Results and Update
11 Aug 2025 //
GLOBENEWSWIRE
Capricor Therapeutics Schedules Type A Meeting with U.S. FDA
08 Aug 2025 //
GLOBENEWSWIRE
Capricor Therapeutics to Present Q2 2025 Financial Results
06 Aug 2025 //
GLOBENEWSWIRE
Capricor Shares Sink as US FDA Declines to Approve Cell Therapy
14 Jul 2025 //
REUTERS
Capricor Says FDA May Not Convene Panel for Co`s Cell Therapy
25 Jun 2025 //
REUTERS
Capricor Therapeutics Reports Q1 2025 Financial Results
13 May 2025 //
GLOBENEWSWIRE
Capricor Therapeutics to Present Q1 2025 Results on May 13
06 May 2025 //
GLOBENEWSWIRE
US FDA panel for Capricor Therapeutics` DMD cell therapy
06 May 2025 //
GLOBENEWSWIRE
Capricor Therapeutics to Present at 2025 Piper Sandler Cardio Day
01 Apr 2025 //
GLOBENEWSWIRE
Capricor Therapeutics Reports Q4 & Full-Year 2024 Results
19 Mar 2025 //
GLOBENEWSWIRE
Capricor Therapeutics to Present Q4 and Full Year 2024 Financial
11 Mar 2025 //
GLOBENEWSWIRE
Capricor Gets FDA Priority Review For Deramiocel In DMD
04 Mar 2025 //
GLOBENEWSWIRE
Capricor Therapeutic to Participate in Upcoming Investor Conference
10 Feb 2025 //
GLOBENEWSWIRE
Capricor Completes Submission of BLA for Deramiocel for DMD
02 Jan 2025 //
GLOBENEWSWIRE
Capricor Therapeutics to Present at Upcoming Investor Conferences
02 Dec 2024 //
GLOBENEWSWIRE
Capricor Reports Q3 2024 Results & Corporate Update
13 Nov 2024 //
GLOBENEWSWIRE
Capricor to Present Exosome Platform Updates at 2024 AEV Annual Meeting
12 Nov 2024 //
GLOBENEWSWIRE
Capricor Therapeutics Closes Underwritten Public Offering
18 Oct 2024 //
GLOBENEWSWIRE
Capricor Therapeutics Prices $75 Million Public Offering of Stock
17 Oct 2024 //
GLOBENEWSWIRE
Capricor Therapeutics Proposes Public Offering Of Common Stock
16 Oct 2024 //
GLOBENEWSWIRE
Capricor shares more data for DMD therapy after initiating BLA
11 Oct 2024 //
FIERCE BIOTECH
Capricor Announces Data from Study in DMD at Muscle Society Congress
11 Oct 2024 //
GLOBENEWSWIRE
Capricor Therapeutics Initiates Rolling BLA For Deramiocel In DMD
09 Oct 2024 //
GLOBENEWSWIRE
Capricor To Present Long-Term Data From HOPE-2 Study At Congress
04 Oct 2024 //
GLOBENEWSWIRE
Capricor Therapeutics to File Application for Deramiocel Approval
24 Sep 2024 //
GLOBENEWSWIRE
Capricor To Provide Duchenne Muscular Dystrophy Update
23 Sep 2024 //
GLOBENEWSWIRE
Capricor Signs Term Sheet With Nippon Shinyaku for Europe
17 Sep 2024 //
GLOBENEWSWIRE
Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences
06 Sep 2024 //
GLOBENEWSWIRE
Capricor Therapeutics Reports Q2 2024 Results And Corporate Update
07 Aug 2024 //
GLOBENEWSWIRE
Capricor Therapeutics Announces +ve Type-B Meeting with FDA for CAP-1002 Program
11 Jun 2024 //
GLOBENEWSWIRE
Capricor: Positive 3-Year CAP-1002 Efficacy In Duchenne Muscular Dystrophy
04 Jun 2024 //
GLOBENEWSWIRE
Capricor`s Positive FDA Meeting for DMD Drug CAP-1002
24 Apr 2024 //
GLOBENEWSWIRE
Capricor Announces Continuation of Phase 3 HOPE-3 Trial of CAP-1002
11 Dec 2023 //
GLOBENEWSWIRE
Capricor Announces Type-B Meeting to Discuss Pathway to BLA for CAP-1002
29 Sep 2023 //
GLOBENEWSWIRE
Capricor Announces +ve 24-Month Results from Ongoing HOPE-2 Study of CAP-1002
30 Jun 2023 //
GLOBENEWSWIRE
Capricor to Present Results from HOPE-2 Extension Study of CAP-1002
13 Jun 2023 //
GLOBENEWSWIRE
Capricor Announces Follow-up Type-B Meeting with the FDA for CAP-1002
07 Jun 2023 //
GLOBENEWSWIRE
Capricor Announces Peer-Reviewed PublicationTherapeutic Potential of Exosome
27 Apr 2023 //
GLOBENEWSWIRE
Capricor Announces Results from HOPE-2 Open Label Extension Study of CAP-1002
25 Jan 2023 //
GLOBENEWSWIRE
Capricor Announces Publication Highlighting Engineered Exosome Platform
12 Jan 2023 //
GLOBENEWSWIRE
